Exelixis (EXEL) EPS (Weighted Average and Diluted) (2010 - 2026)

Exelixis (EXEL) recorded quarterly EPS (Weighted Average and Diluted) of $0.79 in Q2 2026, down 10.23% quarter-over-quarter from $0.88 in Q1 2026, and up 43.64% on a YoY basis from $0.55 in Q2 2025.

Exelixis (EXEL) EPS (Weighted Average and Diluted) (2010 - 2026) Analysis & Trends

Exelixis' EPS (Weighted Average and Diluted) history runs 15 years deep, the most recent figure standing at $0.79 for Q2 2026.

  • In Q2 2026, EPS (Weighted Average and Diluted) rose 43.64% year-over-year to $0.79; the TTM figure through Apr 2026 stood at $3.01 (up 36.82% YoY), while the FY2026 annual figure was $2.78, up 57.95% from the prior year.
  • EPS (Weighted Average and Diluted) was $0.79 for Q2 2026 at Exelixis, down from $0.88 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.88 in Q1 2026 to a low of -$0.09 in Q4 2022.
  • Historically, EPS (Weighted Average and Diluted) has averaged $0.38 across 5 years, with a median of $0.27 in 2023.
  • The sharpest annual moves came in 2022 and 2024: EPS (Weighted Average and Diluted) sank 130.49% in 2022, then soared 12360.21% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.09 in 2022, then soared by 400.0% to $0.27 in 2023, then surged by 48.15% to $0.4 in 2024, then jumped by 72.5% to $0.69 in 2025, then grew by 14.49% to $0.79 in 2026.
  • The last three EPS (Weighted Average and Diluted) figures came in at $0.79 (Q2 2026), $0.88 (Q1 2026), and $0.69 (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 0.68
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 3.06
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 3,086.42
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 0.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 0.00
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 4.02
9 Abivax 94.37 Bn 94.37 Bn - -0.61
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn 0.79

Historic Data

Download Data
DateValue
Apr 3, 2026 0.79
Jan 2, 2026 0.88
Oct 3, 2025 0.69
Jul 4, 2025 0.65
Apr 4, 2025 0.55
Jan 3, 2025 0.48
Sep 27, 2024 0.40
Jun 28, 2024 0.77
Mar 29, 2024 0.12
Dec 29, 2023 0.27
Sep 29, 2023 0.00
Jun 30, 2023 0.25
Mar 31, 2023 0.12
Dec 30, 2022 -0.09
Sep 30, 2022 0.23
Jul 1, 2022 0.22
Apr 1, 2022 0.21
Dec 31, 2021 0.30
Oct 1, 2021 0.12
Jul 2, 2021 0.30